Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Philip O'Keefe"


4 mentions found


Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. Synchron announced Thursday that it has acquired a minority equity stake in the German manufacturer Acquandas, which has the unique ability to layer the metals that make up one component of the company's implant. Founded in 2012, Synchron has developed a brain-computer interface, or a BCI, called the Synchron Switch. During initial studies, Synchron has so far implanted six patients in the U.S. and four patients in Australia. Synchron declined to share the specific size of Synchron's stake in Acquandas or the exact number of devices it is producing.
Persons: Philip O'Keefe, Synchron, Tom Oxley, Riki Banerjee, Oxley, Acquandas Organizations: BCI, U.S . Food, Drug Administration, CNBC Locations: U.S, Australia, Acquandas
Neurosity's device is designed to help people focus, but some developers are using it as a BCI. "Getting a non invasive brain computer interface for my birthday (!!!!? Grimes' birthday 'Crown' measures brain activity, and is designed to help people focusNeurosity's headset uses electroencephalogram technology, or EEG, to measure brain activity by placing small metal electrodes on a person's scalp. In a now-deleted tweet, the singer said Neurosity's device allowed her to use her mind to move a cursor. Meanwhile, Neurosity's device is already on the market.
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, using his BCI. Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. About 20 months earlier, O'Keefe was implanted with Synchron's BCI. Synchron's technology has caught the attention of its competitors. Source: SynchronIn January, the medical journal JAMA Neurology published the peer-reviewed, long-term safety results from a trial of Synchron's BCI system in Australia.
Tech moguls like Elon Musk, Jeff Bezos, and Bill Gates are investing in brain-implant startups. Through their venture-capital funds, Jeff Bezos and Bill Gates both recently backed the Brooklyn, New York, startup Synchron, which has tested its brain stent in seven humans. Peter Thiel, a billionaire cofounder of PayPal, invested last year in Utah's Blackrock Neurotech, an older BCI startup that has said it hopes to apply for Food and Drug Administration approval soon. That long-term potential has caught the attention of tech billionaires like Musk, Gates, and Bezos. No BCI startup has gone public, and most of their fundraising rounds have been modest compared with larger and more-mature biotechs.
Total: 4